We  ||| S:0 E:3 ||| PRP
should  ||| S:3 E:10 ||| MD
abandon  ||| S:10 E:18 ||| VB
randomized  ||| S:18 E:29 ||| VBN
controlled  ||| S:29 E:40 ||| VBN
trials  ||| S:40 E:47 ||| NNS
in  ||| S:47 E:50 ||| IN
the  ||| S:50 E:54 ||| DT
intensive  ||| S:54 E:64 ||| JJ
care  ||| S:64 E:69 ||| NN
unit  ||| S:69 E:74 ||| NN
The  ||| S:74 E:78 ||| DT
randomized  ||| S:78 E:89 ||| JJ
controlled  ||| S:89 E:100 ||| JJ
trial  ||| S:100 E:106 ||| NN
is  ||| S:106 E:109 ||| VBZ
seen  ||| S:109 E:114 ||| VBN
by  ||| S:114 E:117 ||| IN
many  ||| S:117 E:122 ||| JJ
as  ||| S:122 E:125 ||| IN
the  ||| S:125 E:129 ||| DT
summit  ||| S:129 E:136 ||| NN
of  ||| S:136 E:139 ||| IN
evidence-based  ||| S:139 E:154 ||| JJ
medicine ||| S:154 E:162 ||| NN
,  ||| S:162 E:164 ||| ,
yet ||| S:164 E:167 ||| RB
,  ||| S:167 E:169 ||| ,
in  ||| S:169 E:172 ||| IN
the  ||| S:172 E:176 ||| DT
intensive  ||| S:176 E:186 ||| JJ
care  ||| S:186 E:191 ||| NN
unit ||| S:191 E:195 ||| NN
,  ||| S:195 E:197 ||| ,
randomized  ||| S:197 E:208 ||| VBD
controlled  ||| S:208 E:219 ||| VBN
trials  ||| S:219 E:226 ||| NNS
can  ||| S:226 E:230 ||| MD
be  ||| S:230 E:233 ||| VB
challenging  ||| S:233 E:245 ||| VBG
to  ||| S:245 E:248 ||| TO
conduct ||| S:248 E:255 ||| VB
,  ||| S:255 E:257 ||| ,
and  ||| S:257 E:261 ||| CC
results  ||| S:261 E:269 ||| NNS
are  ||| S:269 E:273 ||| VBP
often  ||| S:273 E:279 ||| RB
difficult  ||| S:279 E:289 ||| JJ
to  ||| S:289 E:292 ||| TO
interpret  ||| S:292 E:302 ||| VB
and  ||| S:302 E:306 ||| CC
apply ||| S:306 E:311 ||| VB
.  ||| S:311 E:313 ||| .
Many  ||| S:313 E:318 ||| JJ
randomized  ||| S:318 E:329 ||| NNS
controlled  ||| S:329 E:340 ||| VBN
trials  ||| S:340 E:347 ||| NNS
in  ||| S:347 E:350 ||| IN
intensive  ||| S:350 E:360 ||| JJ
care  ||| S:360 E:365 ||| NN
patients  ||| S:365 E:374 ||| NNS
have  ||| S:374 E:379 ||| VBP
not  ||| S:379 E:383 ||| RB
demonstrated  ||| S:383 E:396 ||| VBN
beneficial  ||| S:396 E:407 ||| JJ
effects  ||| S:407 E:415 ||| NNS
of  ||| S:415 E:418 ||| IN
the  ||| S:418 E:422 ||| DT
intervention  ||| S:422 E:435 ||| NN
under  ||| S:435 E:441 ||| IN
investigation  ||| S:441 E:455 ||| NN
often  ||| S:455 E:461 ||| RB
despite  ||| S:461 E:469 ||| IN
good  ||| S:469 E:474 ||| JJ
preclinical  ||| S:474 E:486 ||| NN
and  ||| S:486 E:490 ||| CC
even  ||| S:490 E:495 ||| RB
previous  ||| S:495 E:504 ||| JJ
randomized  ||| S:504 E:515 ||| NNS
controlled  ||| S:515 E:526 ||| VBN
trial  ||| S:526 E:532 ||| NN
evidence ||| S:532 E:540 ||| NN
.  ||| S:540 E:542 ||| .
There  ||| S:542 E:548 ||| EX
are  ||| S:548 E:552 ||| VBP
many  ||| S:552 E:557 ||| JJ
reasons  ||| S:557 E:565 ||| NNS
for  ||| S:565 E:569 ||| IN
these  ||| S:569 E:575 ||| DT
negative  ||| S:575 E:584 ||| JJ
results  ||| S:584 E:592 ||| NNS
including  ||| S:592 E:602 ||| VBG
problems  ||| S:602 E:611 ||| NNS
with  ||| S:611 E:616 ||| IN
timing ||| S:616 E:622 ||| NN
,  ||| S:622 E:624 ||| ,
end  ||| S:624 E:628 ||| NN
point  ||| S:628 E:634 ||| NN
selection ||| S:634 E:643 ||| NN
,  ||| S:643 E:645 ||| ,
and  ||| S:645 E:649 ||| CC
heterogeneous  ||| S:649 E:663 ||| JJ
populations ||| S:663 E:674 ||| NNS
.  ||| S:674 E:676 ||| .
In  ||| S:676 E:679 ||| IN
this  ||| S:679 E:684 ||| DT
article ||| S:684 E:691 ||| NN
,  ||| S:691 E:693 ||| ,
we  ||| S:693 E:696 ||| PRP
will  ||| S:696 E:701 ||| MD
discuss  ||| S:701 E:709 ||| VB
the  ||| S:709 E:713 ||| DT
limitations  ||| S:713 E:725 ||| NNS
of  ||| S:725 E:728 ||| IN
randomized  ||| S:728 E:739 ||| JJ
controlled  ||| S:739 E:750 ||| JJ
trials  ||| S:750 E:757 ||| NNS
in  ||| S:757 E:760 ||| IN
the  ||| S:760 E:764 ||| DT
intensive  ||| S:764 E:774 ||| JJ
care  ||| S:774 E:779 ||| NN
unit  ||| S:779 E:784 ||| NN
population  ||| S:784 E:795 ||| NN
and  ||| S:795 E:799 ||| CC
highlight  ||| S:799 E:809 ||| VB
the  ||| S:809 E:813 ||| DT
importance  ||| S:813 E:824 ||| NN
of  ||| S:824 E:827 ||| IN
considering  ||| S:827 E:839 ||| VBG
other  ||| S:839 E:845 ||| JJ
study  ||| S:845 E:851 ||| NN
designs  ||| S:851 E:859 ||| NNS
in  ||| S:859 E:862 ||| IN
the  ||| S:862 E:866 ||| DT
challenging  ||| S:866 E:878 ||| JJ
intensive  ||| S:878 E:888 ||| JJ
care  ||| S:888 E:893 ||| NN
unit  ||| S:893 E:898 ||| NN
environment ||| S:898 E:909 ||| NN
.  ||| S:909 E:911 ||| .
